Device Trial Radar · NCT04824885
Study of a Dialysate Without Acetate on Protein Energy Wasting Syndrome in Chronic Hemodialysis Patient (EASY)
Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
60
Actual
Start
Feb 15, 2022
Primary completion
Mar 6, 2025
Study completion Mar 6, 2025
Sponsor
- Lead sponsor
- University Hospital, Clermont-FerrandAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- INRAE
- First posted
- Apr 1, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This work aims to study the effect of an acetate-free dialysate on protein-energy wasting syndrome in patients with chronic hemodialysis renal failure, in comparison to a conventional dialysate with acetate. The hypothesis is that a dialysate without acetate would improve patients nutritional status
Conditions
- End Stage Renal Disease
- Hemodialysis
Interventions
Chlorhydric acid based acid concentrate for bicarbonate hemodialysis (medical device)Device
usual dialysate (A + D) for 6 months and then switch to A-D dialysate for the next 6 months
Primary outcomes
What the sponsor says the trial is designed to measure.
- prealbuminTime frame: change at 6 months from the start of Acetate free or acetate containing dialysate
Locations
1 site in 1 country. Site status is shown where the registry gives one.
CHU de Clermont-Ferrand
Clermont-Ferrand, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.